Meng Lyu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Meng Lyu has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Xufei Luo
Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences (2021RU017), School of Basic Medical Sciences, Lanzhou University, Lanzhou, China
3 shared publications - Yaolong Chen
School of Public Health, Lanzhou University
3 shared publications - Di Zhu
Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China
2 shared publications - Fengxian Chen
School of Information Science & Engineering, Lanzhou University, Lanzhou, China
2 shared publications - Hui Liu
Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China
2 shared publications - Ling Wang
Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China
2 shared publications
Latest Publications
- Open Access
- 31 July 2026
- Published by Springer Nature in The European Physical Journal C
- Vol. 86 (7) , 911
Construction and characterization of a muon trigger detector for the PSI muEDM experiment
We present the upgraded design, construction, and beam test results for the muon trigger detector (MTD) developed for the muon electric dipole moment (muEDM) experiment at the Paul Scherrer Institute (PSI) in Switzerland. This experiment aims to improve the sensitivity of the muon EDM measurement by more than three orders of magnitude beyond the current limit established by the BNL Muon $$g-2$$ experiment. Precise identification of storable incoming muons at the entrance of the storage solenoid is essential, as the MTD must rapidly trigger a pulsed magnetic kicker to confine muons in the central region of the solenoid, where a weakly focusing magnetic field is maintained. The MTD comprises two subsystems: a 0.1 mm-thick plastic scintillator “gate detector” read out by four silicon photomultipliers (SiPMs), and a 5 mm-thick CNC-machined plastic scintillator “active aperture detector” read out by six SiPMs. The geometry of the active aperture detector was optimized through acceptance studies to maximize both storage efficiency and background veto efficiency. Integrated fast electronics generate an LVTTL trigger signal under an anti-coincidence condition – a muon detected in the gate but not in the aperture – ensuring selective triggering of storable muon events for the EDM measurement. The system was tested at the PSI $$\pi $$ E1 beamline using 22.5 MeV/ c muons under scaled-down conditions to characterize detector response and trigger performance. A Geant4 simulation incorporating detailed optical photon transport and SiPM response modeling was developed and reproduces the measured event topologies with $${\sim }97\%$$ agreement. These results validate the detector design and demonstrate the MTD’s readiness for deployment in the full muEDM Phase-1 setup.- 31 July 2026
- Published by Springer Nature in The European Physical Journal C
- Vol. 86 (7) , 911
Open AccessConstruction and characterization of a muon trigger detector for the PSI muEDM experiment
We present the upgraded design, construction, and beam test results for the muon trigger detector (MTD) developed for the muon electric dipole moment (muEDM) experiment at the Paul Scherrer Institute (PSI) in Switzerland. This experiment aims to improve the sensitivity of the muon EDM measurement by more than three orders of magnitude beyond the current limit established by the BNL Muon $$g-2$$ experiment. Precise identification of storable incoming muons at the entrance of the storage solenoid is essential, as the MTD must rapidly trigger a pulsed magnetic kicker to confine muons in the central region of the solenoid, where a weakly focusing magnetic field is maintained. The MTD comprises two subsystems: a 0.1 mm-thick plastic scintillator “gate detector” read out by four silicon photomultipliers (SiPMs), and a 5 mm-thick CNC-machined plastic scintillator “active aperture detector” read out by six SiPMs. The geometry of the active aperture detector was optimized through acceptance studies to maximize both storage efficiency and background veto efficiency. Integrated fast electronics generate an LVTTL trigger signal under an anti-coincidence condition – a muon detected in the gate but not in the aperture – ensuring selective triggering of storable muon events for the EDM measurement. The system was tested at the PSI $$\pi $$ E1 beamline using 22.5 MeV/ c muons under scaled-down conditions to characterize detector response and trigger performance. A Geant4 simulation incorporating detailed optical photon transport and SiPM response modeling was developed and reproduces the measured event topologies with $${\sim }97\%$$ agreement. These results validate the detector design and demonstrate the MTD’s readiness for deployment in the full muEDM Phase-1 setup. - Top Cited PapersOpen Access
- 25 June 2024
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26, e56780
Potential Roles of Large Language Models in the Production of Systematic Reviews and Meta-Analyses
Large language models (LLMs) such as ChatGPT have become widely applied in the field of medical research. In the process of conducting systematic reviews, similar tools can be used to expedite various steps, including defining clinical questions, performing the literature search, document screening, information extraction, and language refinement, thereby conserving resources and enhancing efficiency. However, when using LLMs, attention should be paid to transparent reporting, distinguishing between genuine and false content, and avoiding academic misconduct. In this viewpoint, we highlight the potential roles of LLMs in the creation of systematic reviews and meta-analyses, elucidating their advantages, limitations, and future research directions, aiming to provide insights and guidance for authors planning systematic reviews and meta-analyses.
- 25 June 2024
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26, e56780
Top Cited PapersOpen AccessPotential Roles of Large Language Models in the Production of Systematic Reviews and Meta-Analyses
Large language models (LLMs) such as ChatGPT have become widely applied in the field of medical research. In the process of conducting systematic reviews, similar tools can be used to expedite various steps, including defining clinical questions, performing the literature search, document screening, information extraction, and language refinement, thereby conserving resources and enhancing efficiency. However, when using LLMs, attention should be paid to transparent reporting, distinguishing between genuine and false content, and avoiding academic misconduct. In this viewpoint, we highlight the potential roles of LLMs in the creation of systematic reviews and meta-analyses, elucidating their advantages, limitations, and future research directions, aiming to provide insights and guidance for authors planning systematic reviews and meta-analyses.
- Open Access
- 20 February 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Potential Roles of Large Language Models in the Production of Systematic Reviews and Meta-Analyses (Preprint)
UNSTRUCTURED Large language models (LLMs) such as ChatGPT have become widely applied in the field of medical research. In the process of conducting systematic reviews, similar tools can be used to expedite various steps, including defining clinical questions, performing the literature search, document screening, information extraction, and language refinement, thereby conserving resources and enhancing efficiency. However, when using LLMs, attention should be paid to transparent reporting, distinguishing between genuine and false content, and avoiding academic misconduct. In this viewpoint, we highlight the potential roles of LLMs in the creation of systematic reviews and meta-analyses, elucidating their advantages, limitations, and future research directions, aiming to provide insights and guidance for authors planning systematic reviews and meta-analyses.
- 20 February 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPotential Roles of Large Language Models in the Production of Systematic Reviews and Meta-Analyses (Preprint)
UNSTRUCTURED Large language models (LLMs) such as ChatGPT have become widely applied in the field of medical research. In the process of conducting systematic reviews, similar tools can be used to expedite various steps, including defining clinical questions, performing the literature search, document screening, information extraction, and language refinement, thereby conserving resources and enhancing efficiency. However, when using LLMs, attention should be paid to transparent reporting, distinguishing between genuine and false content, and avoiding academic misconduct. In this viewpoint, we highlight the potential roles of LLMs in the creation of systematic reviews and meta-analyses, elucidating their advantages, limitations, and future research directions, aiming to provide insights and guidance for authors planning systematic reviews and meta-analyses.
- Open Access
Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review
Aim: To identify the safety, immunogenicity, and protective efficacy of COVID-19 vaccines in children and adolescents. Methods: We conducted a systematic review of published studies and ongoing clinical studies related to the safety, immunogenicity, and efficacy of COVID-19 vaccine in children or adolescents (aged < 18 years). Databases including PubMed, Web of Science, WHO COVID-19 database, and China National Knowledge Infrastructure (CNKI) were searched on 23 July 2021. International Clinical Trials Registry Platform (ICTRP) was also searched to identify ongoing studies. Results: Eight published studies with a total of 2852 children and adolescents and 28 ongoing clinical studies were included. Of the eight published studies, two were RCTs, two case series, and four case reports. The investigated COVID-19 vaccines had good safety profiles in children and adolescents. Injection site pain, fatigue, headache, and chest pain were the most common adverse events. A limited number of cases of myocarditis and pericarditis were reported. The RCTs showed that the immune response to BNT162b2 in adolescents aged 12–15 years was non-inferior to that in young people aged 16–25 years, while with 3 μg CoronaVac injection the immune response was stronger than with 1.5 μg. The efficacy of BNT162b2 was 100% (95% CI: 75.3 to 100), based on one RCT. Of the 28 ongoing clinical studies, twenty-three were interventional studies. The interventional studies were being conducted in fifteen countries, among them, China (10, 43.5%) and United States(9, 39.1%) had the highest number of ongoing trials. BNT162b2 was the most commonly studied vaccine in the ongoing trials. Conclusion: Two COVID-19 vaccines have potential protective effects in children and adolescents, but awareness is needed to monitor possible adverse effects after injection. Clinical studies of the COVID-19 vaccination in children and adolescents with longer follow-up time, larger sample size, and a greater variety of vaccines are still urgently needed.
Open AccessSafety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review
Aim: To identify the safety, immunogenicity, and protective efficacy of COVID-19 vaccines in children and adolescents. Methods: We conducted a systematic review of published studies and ongoing clinical studies related to the safety, immunogenicity, and efficacy of COVID-19 vaccine in children or adolescents (aged < 18 years). Databases including PubMed, Web of Science, WHO COVID-19 database, and China National Knowledge Infrastructure (CNKI) were searched on 23 July 2021. International Clinical Trials Registry Platform (ICTRP) was also searched to identify ongoing studies. Results: Eight published studies with a total of 2852 children and adolescents and 28 ongoing clinical studies were included. Of the eight published studies, two were RCTs, two case series, and four case reports. The investigated COVID-19 vaccines had good safety profiles in children and adolescents. Injection site pain, fatigue, headache, and chest pain were the most common adverse events. A limited number of cases of myocarditis and pericarditis were reported. The RCTs showed that the immune response to BNT162b2 in adolescents aged 12–15 years was non-inferior to that in young people aged 16–25 years, while with 3 μg CoronaVac injection the immune response was stronger than with 1.5 μg. The efficacy of BNT162b2 was 100% (95% CI: 75.3 to 100), based on one RCT. Of the 28 ongoing clinical studies, twenty-three were interventional studies. The interventional studies were being conducted in fifteen countries, among them, China (10, 43.5%) and United States(9, 39.1%) had the highest number of ongoing trials. BNT162b2 was the most commonly studied vaccine in the ongoing trials. Conclusion: Two COVID-19 vaccines have potential protective effects in children and adolescents, but awareness is needed to monitor possible adverse effects after injection. Clinical studies of the COVID-19 vaccination in children and adolescents with longer follow-up time, larger sample size, and a greater variety of vaccines are still urgently needed.